Abildgaard, M O; Borre, M; Mortensen, M M; Ulhøi, B P; Tørring, N; Wild, P; Kristensen, H; Mansilla, F; Ottosen, P D; Dyrskjøt, L; Orntoft, T F; Sørensen, K D (2011). Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis. International Journal of Cancer:1-11.
Sørensen, K D; Wild, P J; Mortezavi, A; Adolf, K; Tørring, N; Heebøll, S; Ulhøi, B P; Ottosen, P; Sulser, T; Hermanns, T; Moch, H; Borre, M; Ørntoft, T F; Dyrskjøt, L (2009). Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 15(4):1400-1410.